Total planned funding: $162,446,036
Allocations
Countries/Regions
| India | $162,446,036 |
Organizational Types
| NGO | $62,445,894 |
| Unknown | $41,716,888 |
| Own Agency | $27,228,870 |
| University | $22,582,112 |
| Private Contractor | $2,589,272 |
| Multi-lateral Agency | $2,400,000 |
| Host Country Government Agency | $1,348,400 |
| FBO | $1,100,000 |
| Other USG Agency | $1,034,600 |
| Implementing Agency | $0 |
Program Areas
| Governance and Systems | $57,204,790 |
| Prevention | $42,943,080 |
| Care | $25,947,661 |
| Management and Operations | $19,240,784 |
| Testing | $9,140,746 |
| Treatment | $7,968,975 |
Budget Codes
| OHSS: Health Systems Strengthening | $33,452,387 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $25,626,509 |
| HVSI: Strategic Information | $19,499,341 |
| HVMS: Management and Operations | $19,240,784 |
| HBHC: Care: Adult Care and Support | $17,504,604 |
| HVCT: Testing: HIV Testing and Counseling | $9,140,746 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,856,381 |
| HTXS: Treatment: Adult Treatment | $7,633,704 |
| HKID: Care: Orphans and Vulnerable Children | $5,326,009 |
| HLAB: Laboratory Infrastructure | $4,253,062 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,580,468 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,355,455 |
| HVTB: Care: TB/HIV | $2,635,741 |
| HMBL: Biomedical Prevention: Blood Safety | $2,514,267 |
| PDCS: Care: Pediatric Care and Support | $481,307 |
| PDTX: Treatment: Pediatric Treatment | $311,794 |
| HTXD: Treatment: ARV Drugs | $23,477 |
| HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$40,044,910
Countries/Regions
FHI 360:
$15,981,011
Countries/Regions
Voluntary Health Services:
$14,540,000
Countries/Regions
University of Manitoba:
$13,592,112
Countries/Regions
USG Aggregated Agencies:
$10,707,272
Countries/Regions